Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in The New York Times on December 17, 2010 titled “Court Backs Patents for Diagnostic Tests.” Brinckerhoff discusses a Court of Appeals for the Federal Circuit ruling which upholds that diagnostic tests used to determine whether a patient is getting the proper dose of a medicine can be patented. She states that the decision will be welcomed by those working in personalized medicine and may help improve both the clinical efficacy and cost-efficiency of therapeutic treatment.
People
Related News
June 16, 2025
In the News
Gregory Husisian on Customs Compliance Violations – 'It's a sharply increased risk profile'
Foley & Lardner LLP partner Gregory Husisian joined the SupplyChainBrain Thought Leaders episode, "Getting Ahead of Customs Compliance Violations," to describe the heightened risk environment importers face under the current trade and regulatory regime.
June 11, 2025
In the News
Foley Named Top US Firm for IP Lateral Hires by ManagingIP
Foley & Lardner LLP was named the top United States firm for intellectual property lateral partner hires in April and May 2025 based on data from ManagingIP's Talent Tracker.
June 10, 2025
In the News
Lynn Gandhi Sheds Light on Supreme Court Tax Ruling
Foley partner Lynn Gandhi commented in the Bloomberg Tax article "High Court’s Catholic Charities Case to Go Beyond Unemployment," sharing insight on the implications of a recent Supreme Court ruling in a tax case.